Menstrual Cycle Premenstrual Disorders

Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial

Tully L, Humiston J, Cash A

Published March 25, 2020 Obstetrics & Gynecology Science, 63(2), 195-204
DOI 10.5468/ogs.2020.63.2.195 PMID 32206660 PMC PMC7073356

RRM Academy Synopsis

Oxaloacetate with vitamin C eased PMS emotional symptoms in a trial

In two trials of 48 women with PMS mood symptoms, depression scores improved 54.1% on oxaloacetate with vitamin C and 30.7% on placebo. Anxiety, stress and aggression scores also improved more on the supplement.

Key Findings

  • Depression scores improved 54.1% over baseline with oxaloacetate and vitamin C and 30.7% with placebo; the difference between the two was P<0.01.
  • Perceived stress improved 35.8% against 18.0% with placebo (P<0.001), and generalized anxiety improved 51.4% against 27.0% (P<0.001).
  • Aggression scores improved 17.8% with oxaloacetate and vitamin C and 6.8% with placebo (P<0.01). In part A alone, the difference had P=0.060.
  • Among 31 women with suicidal ideation at baseline, the Beck's Depression Inventory suicidal ideation item showed a mean improvement of 47.9% over baseline with oxaloacetate and vitamin C (P<0.0001).
  • The paper reports that no side effects or adverse effects occurred in the study population with oxaloacetate and vitamin C.

Interpretation

This research combined a randomized, double-blind crossover trial of 26 women with a second group of 22 women who took the supplement after placebo, each completing symptom questionnaires over two menstrual cycles. Women were recruited online based on self-reported emotional PMS symptoms, and those with premenstrual dysphoric disorder or diagnosed depression were excluded. The authors note a carryover effect from the supplement into the following month, significant for depression scores. They propose that a glucose shortage in the brain may underlie PMS mood symptoms. The findings support larger studies of oxaloacetate and vitamin C for PMS mood symptoms.

RRM Context

Restorative reproductive medicine looks for the underlying cause of symptoms that follow the ovulatory cycle. Premenstrual symptoms occur in the luteal phase, the days after ovulation. Cycle charting records when they begin and end. The trial's outcome measures were four symptom questionnaires.

Abstract

Objective

Premenstrual syndrome (PMS) affects millions of women. While over-the-counter products have helped with the physical symptoms of PMS, emotional symptoms have been less well supported. The objective of this trial was to measure the effect of an oxaloacetate/vitamin C combination on the major emotional symptoms of PMS, including depression, anxiety, perceived stress, aggression, and suicidal ideation.

Methods

Forty-eight women experiencing PMS completed a baseline survey comprising the Beck's Depression Inventory, Cohen Perceived Stress Scale, Generalized Anxiety Disorder Test, and Buss-Perry Aggression Questionnaire. After baseline measurements, participants were randomly assigned to take either 2 capsules of 100 mg oxaloacetate/150 mg ascorbic acid, or 2 capsules of rice flour (placebo) for their entire menstrual cycle. At menstruation, the women completed the 4 surveys again. The women then switched capsules in a cross-over design and continued the study for an additional menstrual cycle. The final assessment was repeated at menstruation. Statistical analysis of the 4 surveys was performed to examine efficacy.

Results

Oxaloacetate/vitamin C supplementation during PMS significantly improved depression, perceived stress, anxiety, aggression, and suicidal ideation. The mean improvement in depression was 54.1%, 35.8% for perceived stress, 51.43% for generalized anxiety, and 17.8% for aggression. Suicidal ideation was reduced by 47.9%. All results were highly significant.

Conclusion

A combination of oxaloacetate and vitamin C supplementation helped to alleviate depression, anxiety, perceived stress, aggression, and suicidal ideation symptoms associated with PMS.

Trial Registration

ClinicalTrials.gov Identifier: NCT03509714.

Topics

Related research

Menstrual Cycle › Premenstrual Disorders › Premenstrual Syndrome Treatment · Mental Health and Psychosocial Care › Mood and the Cycle › Cyclical Mood Symptoms
Lisa Tully, John Humiston, Alan Cash
L Tully, Jack Humiston, J Humiston, A Cash
PMID 32206660 32206660 DOI 10.5468/ogs.2020.63.2.195 10.5468/ogs.2020.63.2.195 Tully et al. 2020, Tully 2020